Saxagliptin Triple Oral Therapy

Clinical trial NCT01128153 · COMPLETED

Trial details

NCT number: NCT01128153
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2010-06-01
Primary completion: 2011-06-01
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.